CymitQuimica logo

CAS 211364-69-1

:

[2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphinic acid

Description:
The chemical substance known as [2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphinic acid, with the CAS number 211364-69-1, is a phosphonic acid derivative that exhibits characteristics typical of nucleoside analogs. This compound features a purine base structure, which is significant for its potential biological activity, particularly in antiviral and anticancer applications. The presence of the phosphinic acid moiety suggests that it may interact with biological systems by mimicking natural nucleotides, potentially inhibiting enzymes involved in nucleic acid synthesis. The ethoxy and isopropoxy groups contribute to its solubility and stability, which are crucial for its efficacy in therapeutic contexts. Additionally, the amino group on the purine ring may enhance its interaction with biological targets. Overall, this compound's unique structural features position it as a candidate for further research in medicinal chemistry, particularly in the development of antiviral agents or other therapeutic applications.
Formula:C14H22N5O7P
InChI:InChI=1/C14H22N5O7P/c1-9(2)26-14(20)23-7-25-27(21,22)8-24-10(3)4-19-6-18-11-12(15)16-5-17-13(11)19/h5-6,9-10H,4,7-8H2,1-3H3,(H,21,22)(H2,15,16,17)
SMILES:CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc12)O
Synonyms:
  • Mono-POC Tenofovir
  • ((((R)-1-(6-aMino-9H-purin-9-yl)propan-2-yloxy)Methyl)(hydroxy)phosphoryloxy)Methyl isopropyl carbonate
  • Mono-POC PMPA
  • Tenofovirdisoproxil Impurity I
  • 2,4,7-Trioxa-5-phosphanonanoic acid, 9-(6-amino-9H-purin-9-yl)-5-hydroxy-8-methyl-, 1-methylethyl ester, 5-oxide, (8R)-
  • Tenofovir Disoproxil Related CoMpound E
  • [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid
  • [2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycar...
  • (Mixture of DiastereoMers)
  • Tenofovir monoisoproxil
  • See more synonyms
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
  • Tenofovir Soproxil (((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(hydroxy)phosphoryl)oxy)methyl isopropyl carbonate)

    CAS:
    <p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>
    Formula:C14H22N5O7P
    Color and Shape:White Off-White Solid
    Molecular weight:403.12569
  • Ref: IN-DA002LB3

    20mg
    673.00€
  • Tenofovir Impurity 132

    CAS:
    Formula:C14H22N5O7P
    Color and Shape:White To Off-White Solid
    Molecular weight:403.33

    Ref: 4Z-T-0212

    5mg
    To inquire
    10mg
    910.00€
    25mg
    1,638.00€
    50mg
    2,366.00€
    100mg
    To inquire
  • Tenofovir Disoproxil Fumarate IP Impurity D

    CAS:
    Formula:C14H22N5O7P
    Molecular weight:403.33

    Ref: ST-EA-CP-T5001

    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • Mono-POC Tenofovir

    CAS:
    <p>Stability Hygroscopic<br>Applications An impurity of Tenofovir Disoproxil (T018505(P)), which is an acyclic phosphonate nucleotide analogue; reverse transcriptase inhibitor. It is used as an anti-HIV agent and an antiviral.<br>References Gan, L., et al.: Drug Metab. Dispos., 24, 344 (1996), Annaert, P., et al.: Pharm. Res., 14, 492 (1997), Naesens, L., et al.: Antimicrob. Agents Chemother., 42, 1568 (1998), Shaw, J. P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007)<br></p>
    Formula:C14H22N5O7P
    Color and Shape:White To Light Beige
    Molecular weight:403.33

    Ref: TR-M567000

    1mg
    359.00€
    10mg
    1,635.00€
    100mg
    6,546.00€
  • Tenofovir isoproxil monoester

    CAS:
    <p>Tenofovir isoproxil monoester is a prodrug of Tenofovir, which is an antiviral drug. Tenofovir prevents the growth of HIV by interfering with the synthesis of viral DNA. The process development stage involves converting Tenofovir to its disoproxil monoester form, which has been shown to have greater antiviral activity than Tenofovir alone. This conversion process involves condensing one molecule of fumarate with two molecules of tenofovir, forming tenofovir disoproxil fumarate (TFD). TFD can be converted back to Tenofovir using hydrolysis and hydrogenation. Impurities in TFD include isopropyl tenofovir and unidentified impurities that are not present in the parent drug, tenofovir. Tenofovir Disoproxil Fumarate was also shown to be more potent than TFD and is undergoing clinical trials for</p>
    Formula:C14H22N5O7P
    Purity:Min. 97 Area-%
    Color and Shape:White/Off-White Solid
    Molecular weight:403.33 g/mol

    Ref: 3D-IT46734

    5mg
    184.00€
    10mg
    293.00€
    25mg
    460.00€
    50mg
    755.00€
    100mg
    1,094.00€